Log in
Enquire now

List of SBIR/STTR awards granted to Hemoshear Therapeutics

List of SBIR/STTR awards granted to Hemoshear Therapeutics
List of SBIR/STTR awards granted to AGILE RF, INC.
List of SBIR/STTR awards granted to Policy Research Associates, Inc
List of SBIR/STTR awards granted to IS3D LLC
List of NGOs in Calgary
CEOs of venture debt companies
where
SBIR/STTR Award Recipient
is
Hemoshear TherapeuticsHemoshear Therapeutics
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
HemoShear Therapeutics, LLC SBIR Phase I Award, April 2015

A SBIR Phase I contract was awarded to Hemoshear Therapeutics in April, 2015 for $255,128.0 USD from the U.S. Department of Health & Human Services.

Hemoshear Therapeutics
Hemoshear Therapeutics
SBIR
1R43DK100136-01A1
Phase I
255,128
April 1, 2015
sbir.gov/node/1044085
‌
HemoShear Therapeutics, LLC SBIR Phase II Award, August 2017

A SBIR Phase II contract was awarded to Hemoshear Therapeutics in August, 2017 for $1,862,227.0 USD from the U.S. Department of Health & Human Services.

Hemoshear Therapeutics
Hemoshear Therapeutics
SBIR
1R44DK115301-01
Phase II
1,862,227
August 1, 2017
sbir.gov/node/1324429
‌
HemoShear Therapeutics, LLC SBIR Phase II Award, August 2015

A SBIR Phase II contract was awarded to Hemoshear Therapeutics in August, 2015 for $1,199,998.0 USD from the U.S. Department of Health & Human Services.

Hemoshear Therapeutics
Hemoshear Therapeutics
SBIR
1R44GM113304-01A1
Phase II
1,199,998
August 5, 2015
sbir.gov/node/1031943
‌
HemoShear Therapeutics, LLC SBIR Phase II Award, September 2016

A SBIR Phase II contract was awarded to Hemoshear Therapeutics in September, 2016 for $1,210,475.0 USD from the U.S. Department of Health & Human Services.

Hemoshear Therapeutics
Hemoshear Therapeutics
SBIR
2R44DK100136-02A1
Phase II
1,210,475
September 1, 2016
sbir.gov/node/1198725
‌
HemoShear Therapeutics, LLC SBIR Phase I Award, March 2015

A SBIR Phase I contract was awarded to Hemoshear Therapeutics in March, 2015 for $463,475.0 USD from the U.S. Department of Health & Human Services.

Hemoshear Therapeutics
Hemoshear Therapeutics
SBIR
1R44DK104456-01
Phase I
463,475
March 1, 2015
sbir.gov/node/1046953
‌
HemoShear Therapeutics, LLC SBIR Phase I Award,

A SBIR Phase I contract was awarded to Hemoshear Therapeutics for $190,786.0 USD from the U.S. Department of Health & Human Services.

Hemoshear Therapeutics
Hemoshear Therapeutics
SBIR
1R43DK091104-01
Phase I
190,786
sbir.gov/node/368295
‌
HemoShear Therapeutics, LLC SBIR Phase II Award,

A SBIR Phase II contract was awarded to Hemoshear Therapeutics for $4,293,883.0 USD from the U.S. Department of Health & Human Services.

Hemoshear Therapeutics
Hemoshear Therapeutics
SBIR
2R44HL102951-02
Phase II
4,293,883
sbir.gov/node/370728
‌
HemoShear Therapeutics, LLC SBIR Phase I Award,

A SBIR Phase I contract was awarded to Hemoshear Therapeutics for $249,013.0 USD from the U.S. Department of Health & Human Services.

Hemoshear Therapeutics
Hemoshear Therapeutics
SBIR
1R43TR001206-01
Phase I
249,013
sbir.gov/node/706345
‌
HemoShear Therapeutics, LLC SBIR Phase I Award,

A SBIR Phase I contract was awarded to Hemoshear Therapeutics for $166,830.0 USD from the U.S. Department of Health & Human Services.

Hemoshear Therapeutics
Hemoshear Therapeutics
SBIR
1R43HL102951-01
Phase I
166,830
sbir.gov/node/15075
‌
HemoShear Therapeutics, LLC SBIR Phase II Award,

A SBIR Phase II contract was awarded to Hemoshear Therapeutics for $1,985,884.0 USD from the U.S. Department of Health & Human Services.

Hemoshear Therapeutics
Hemoshear Therapeutics
SBIR
261201500023C-0-0-0
Phase II
1,985,884
sbir.gov/node/970617
10 results
0 selected
10 results
0 selected
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us

Explore companies

  • Artificial Intelligence
  • Fintech
  • Biotechnology
  • Cybersecurity
  • Semiconductors
  • Electric Vehicles
  • Cloud Computing
  • Robotics
  • SaaS
  • Renewable Energy
  • Venture Capital
  • Blockchain
  • Browse all →